期刊文献+

孕母产前应用硫酸镁与早产儿动脉导管未闭的关系 被引量:8

A case-control study on association between antenatal exposure to magnesium sulfate and patent ductus arteriosus in preterm infants
原文传递
导出
摘要 目的探讨孕母产前应用硫酸镁与早产儿动脉导管未闭(patent ductus arteriosus,PDA)的关系。方法应用1:1配对的病例对照研究方法,对2008年1月至2009年12月在我院新生儿科住院的93例确诊PDA的早产儿(PDA组)和93例胎龄和超声心动图检测时间匹配的动脉导管已关闭的早产儿(对照组)进行回顾性分析,收集孕母产前应用硫酸镁情况及新生儿资料。采用单因素分析、多因素Logistic回归分析等方法进行统计学分析。结果PDA组孕母产前应用硫酸镁51例,而对照组中孕母产前应用硫酸镁34例。PDA组患儿血清镁中位浓度及百分位间距(P25~P75)为0.98mmol/L(0.92~1.32mmol/L),高于对照组[0.90mmol/L(0.82-1.09)mmol/L],差异有统计学意义(Z=3.56,P=0.00)。Logistic回归分析表明孕母产前应用硫酸镁(OR=2.646,95%CI:1.356~5.163,P=0.004)、胎儿窘迫(OR=7.189,95%CI:1.209~42.756,P=0.030);早产儿出生体重(OR=1.842,95%CI:1.087~3.438,P=0.049)、呼吸衰竭(OR=3.499,95%CI:1.256~9.752,P=0.017)和吸氧(OR=0.482,95%CI:0.233~0.999,P=0.045)与早产儿PDA的发生有关。而且趋势卡方检验显示,孕母产前应用硫酸镁累积量、血清镁水平与早产儿PDA呈正相关,具有剂量效应关系(Х趋势^2=7.41,P=0.007;Х趋势^2=12.13,P=0.000)。结论孕母产前应用硫酸镁可能增加早产儿发生PDA的风险,且硫酸镁累积量、早产儿血清镁水平越高,早产儿发生PDA的风险越大。 Objective To identify the association between antenatal exposure to magnesium sulfate and patent ductus arteriosus(PDA) in preterm infants. Methods A 1 : 1 case-control study was conducted on 93 preterm infants with PDA and 93 cases of matched controls without PDA hospitalized in our neonatal intensive care unit between January 2008 and December 2009. Information on antenatal exposure to magnesium sulfate, neonatal birth weight and other perinatal factors was collected and analyzed with univariate analysis, multivariate Logistic regression analysis. Results There were 51 preterm infants exposed to magnesium sulfate antenatally in PDA group and 34 infants in controls. The median (P25-P75) level of neonatal serum magnesium in PDA cases was 0.98 mmol/L (0.92-1.32 mmol/L) ,significantly higher than that in controls [0.90 mmol/L(0. 82-1. 09) mmol/L] (Z = 3.56, P=0.00). Logistic regression analysis showed that PDA in preterm infants was significantly associated with antenatal magnesium sulfate exposure(OR=2. 646,95 %CI: 1. 356-5. 163, P=0.004), fetal distress (OR= 7. 189, 95% CI:1.209-42.756, P=0.030), neonatal birth weight (OR = 1. 842,95 % CI : 1. 087-3. 438, P = 0. 049 ), respiratory failure (OR = 3. 499,95 % CI : 1.256- 9. 752, P=0. 017)and postnatal oxygen inhalation (OR=O. 482,95% CI:0. 233-0. 999, P=0. 045). Also, a significant positive correlation was found between PDA and the dose of magnesium sulfate and the concentrations of serum magnesium in preterm infants (Хtrend^ 2= 7.41, P= 0. 007 ;Хtrend^ 2 = 12. 13, P= 0. 000). Conclusions Antenatal exposure to magnesium sulfate might increase the risk of PDA in preterm infants.
出处 《中华围产医学杂志》 CAS 2010年第6期483-487,共5页 Chinese Journal of Perinatal Medicine
关键词 婴儿 早产 动脉导管未闭 硫酸镁 Infant, premature Ductus arteriosus, patent Magnesium sulfate
  • 相关文献

参考文献17

  • 1Noori S,McCoy M,Friedlich P,et al.Failure of ductus arteriosus closure is associated with increased mortality in preterm infants.Pediatrics,2009,123:e138-e144. 被引量:1
  • 2Agarwal R,Deorari AK,Paul VK.Patent ductus arteriosus in preterm neonates.Indian J Pediatr,2008,75:277-280. 被引量:1
  • 3del moral T,Gonzalez-Quintero VH,Claure N,et al.Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants.J Perinatol,2007,27:154-157. 被引量:1
  • 4Elimian A,Verma R,Ogburn P,et al.Magnesium sulfate and neonatal outcomes of preterm neonates.J Matern Fetal Neonatal Med,2002,12:118-122. 被引量:1
  • 5Doyle LW,Crowther CA,Middleton P,et al.Antenatal magnesium sulfate and neurologic outcome in preterm infants:a systematic review.Obstet Gynecol,2009,113:1327-1333. 被引量:1
  • 6Mittendorf R,Dammann O,Lee KS.Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor.J Perinatol,2006,26.57-63. 被引量:1
  • 7Mittendorf R,Dambrosia J,Dammann O,et al.Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage.J Pediatr,2002,140:540-546. 被引量:1
  • 8Crowther CA,Hiller JE,Doyle LW.Magnesium sulphate for preventing preterm birth in threatened preterm labour.Cochrane Database Syst Rev,2002,(4):CD001060. 被引量:1
  • 9Rantonen T,Kaapa P,Jalonen J,et al.Antenatal magnesium sulphate exposure is associated with prolonged parathyroid hormone suppression in preterm neonates.Acta Paediatr,2001,90:278-281. 被引量:1
  • 10Handwerker SM,Altura BT,Jones KY,et al.Maternalfetal transfer of ionized serum magnesium during the stress of labor and delivery:a human study.J Am Coll Nutr,1995,14:376-381. 被引量:1

二级参考文献15

  • 1冯琪,李源,王颖,郭在晨.早产儿动脉导管未闭的临床研究[J].实用儿科临床杂志,2005,20(2):129-131. 被引量:15
  • 2Noori S, McCoy M, Friedlich P,et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics, 2009, 123 :e138-144. 被引量:1
  • 3Agarwal R, Deorari AK, Paul VK. Patent ductus arteriosus in preterm neonates. Indian J Pediatr, 2008,75:277-280. 被引量:1
  • 4Ekici F,Atasay B, Gunlemez A, et al. Management of patent ductus arteriosus in preterm infants. Anadolu Kardiyol Derg, 2006, 6:28-33. 被引量:1
  • 5Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation, 2006,114 : 1873-1882. 被引量:1
  • 6Hermes-DeSantis ER, Clyrnan RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol, 2006, 26 Suppl 1 :S14-18. 被引量:1
  • 7Kesiak M, Nowiczewski M, Gulczynska E, et al. Can we expect decreasing the incidence of patent ductus arterlosus ( PDA ) in the population of premature neonates who had received antenatal steroid therapy? Ginekol Pol, 2005, 76:812-818. 被引量:1
  • 8Bancalari E, Claure N, Gonzalez A. Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate, 2005, 88:192-201. 被引量:1
  • 9Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev, 2008, 1 :CD000503. 被引量:1
  • 10Satake K, Lee JD, Shimizu H, et al. Effects of magnesium on prostacyclin synthesis and intracellular free calcium concentration in vascular cells. Magnes Res,2004,17:20-27. 被引量:1

共引文献18

同被引文献107

  • 1李艳,韦丽仁.小儿脑瘫的病因研究进展[J].中华中医药杂志,2006,21(9):552-554. 被引量:15
  • 2陈岩,潘银英,江基尧,徐振邦,梁伟民,朱伟强.硫酸镁对脑缺血再灌注损伤的保护作用[J].中华麻醉学杂志,1996,16(10):510-512. 被引量:12
  • 3王林,陈必良,辛晓燕,杨红,张俊茹,张敏.硫酸镁对轻度子痫前期疗效的随机对照临床试验[J].山西医科大学学报,2007,38(8):727-729. 被引量:7
  • 4Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birth-weight infants? Pediatrics, 1995, 95:263-969. 被引量:1
  • 5Conde-Aqudelo A, Romero R. Antenalal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. AmJ Obstet Gynecol, 2009, 200:59S-609. 被引量:1
  • 6Twickler DM, McIntire DD, Alexander JM, et al. Effects of magnesium sulfate on preterm fetal cerebral blood flow using Doppler analysis: a randomized controlled trial. Obstet G-ynecol, 2010, 115:21-25. 被引量:1
  • 7Goni de-Cerio F, Alvarez A, Alvarez FJ, et al. MgSO4 treatment preserves the ischemia induced reduction in S 100 protein without modification of the expression of endothelial tight junction molecules. Histol Histopathol, 2009, 24:1129-1138. 被引量:1
  • 8Doyle LW, Crowther CA. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review. Obstet Gynecol, 2009, 113:1202-1203. 被引量:1
  • 9Mittendorf R, Prydeb PG. A review of the role for magnesium sulphate in preterm labour. BJOG, 2005, 112: 84-88. 被引量:1
  • 10Pryde PG,Mittendorf P,. Contemporary usage of obstelric magnesium sulfale= indication, contraindication, and relevance of dose. Ohstet Gynecol, 2009, 114:669-673. 被引量:1

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部